Pharmacology of gap junctions in the cardiovascular system

Cardiovascular Research

Volumn 62, Issue 2, 2004, Pages 287-298

  Dhein, Stefan ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cardiovascular; Connexin; Gap junctions; Pharmacology; Regulation

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ANTIARRHYTHMIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BREFELDIN A; CANNABINOID; CARBOXYLIC ACID; CARDIAC GLYCOSIDE; CYCLIC AMP DERIVATIVE; FENAMIC ACID DERIVATIVE; GAP JUNCTION PROTEIN; GLYCYRRHIZIC ACID DERIVATIVE; ICOSANOID; ION; LIGAND; MONENSIN; NARCOTIC AGENT; PHORBOL ESTER DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE C INHIBITOR; UNSATURATED FATTY ACID;

ACIDIFICATION; ACTION POTENTIAL; ARRHYTHMOGENESIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE PERMEABILITY; DEPHOSPHORYLATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG STABILITY; ELECTRIC CONDUCTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; GAP JUNCTION; HEART MUSCLE CELL; HUMAN; IC 50; ION CURRENT; NONHUMAN; PH MEASUREMENT; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CONNEXINS; GAP JUNCTIONS; HUMANS; ION CHANNEL GATING; MYOCARDIAL CONTRACTION;

EID: 1942470638     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.01.019     Document Type: Review

References (129)

1. Bennett M.V.L., Zheng X., Sogin M.L. The connexin family tree. Kanno Y., Kataoka K., Shiba Y., Shibata Y., Shimazu T. Intercellular communication through gap junctions. 1995;3-8 Elsevier, Amsterdam.
2. Bruzzone R. Learning the language of cell-cell communication through connexin channels. Genome Biol. 2:2001;4027. Reports.
3. Willeckem K., Eiberger J., Degen J.et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 383:2002;725-737.
4. Buchanan J.W., Saito T., Gettes L.S. The effect of antiarrhythmic drugs, stimulation frequency and potassium induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ. Res. 56:1985;696-703.
5. Kanno S., Kovacs A., Yamada K.A.et al. Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J. Am. Coll. Cardiol. 41:2003;681-686.
6. Yasui K., Kada K., Hojo M.et al. Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myocytes. Cardiovasc. Res. 48:2000;68-76.
7. Li G., Whittaker P., Yao M.et al. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc. Pathol. 11:2002;158-165.
8. Christ G.J., Brink P.R. Analysis of the presence and physiological relevance of subconducting states of connxin43-derived gap junction channels in cultured human corporalvascular smooth muscle cells. Circ. Res. 85:1999;797-803.
9. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19:1998;229-241.
10. De Wit C., Roos F., Bolz S.S.et al. Impaired conduction of vasodilation along arterioles in connexin-40 deficient mice. Circ. Res. 86:2000;649-655.
11. Edwards G., Feletou M., Gardener M.J.et al. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br. J. Pharmacol. 128:1999;1788-1794.
12. Sandow S.L., Tare M., Coleman H.A.et al. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ. Res. 90:2002;1108-1113.
13. Berman R.S., Martin P.E., Evans W.H.et al. Relative contributions of NO and gap junctional communication to endothelium-dependent relaxations of rabbit resistance arteries vary with vessel size. Microvasc. Res. 63:2002;115-128.
14. Zahler S., Hoffmann A., Gloe T.et al. Gap-junctional coupling between neutrophils andendothelial cells: a novel modulator of transendothelial migration. J. Leukoc. Biol. 73:2003;118-126.
15. De Mello W.C. Effects of intracellular injection of calcium and strontium on cell communication in heart. J. Physiol. 250:1975;231-245.
16. Noma A., Tsuboi N. Dependence of junctional conductance on proton, calcium and magnesium ions in cardiac paired cells of guinea pig. J. Physiol. (Lond.). 382:1987;193-211.
17. Rüdisüli A., Weingart R. Electrical properties of gap junction channels in guinea pig ventricular cell pairs revealed by exposure to heptanol. Pflügers Arch. 415:1989;12-21.
18. ++]i on nexal membrane resistance. Pflügers Arch. 409:1987;394-402.
19. Spray D.C., Burt J.M. Structure-activity relations of the cardiac gap junction channel. Am. J. Physiol. 258:1990;C195-C205.
20. Reber W.R., Weingart R. Ungulate cardiac Purkinje fibers: the influence of intracellular pH on the electrical cell-to-cell coupling. J. Physiol. (Lond.). 328:1982;87-104.
21. 2+. Am. J. Physiol. 253:1987;C607-C609.
22. Firek L., Weingart R. Modification of gap junction conductance by divalent cations and protons in neonatal rat heart cells. J. Mol. Cell Cardiol. 27:1995;1633-1643.
23. Hermans M.M.P., Kortekaas P., Jongsma H.J.et al. pH sensitivity of the cardiac gap junction proteins, connexin 45 and 43. Pflügers Arch. 431:1995;138-140.
24. Liu S., Tafet S., Stoner L.et al. A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxy tail length. Biophys. J. 64:1993;1422-1433.
25. Morley G.E., Taffet S.M., Delmar M. Intramolecular interactions mediate pH regulation of connexin43 channels. Biophys. J. 70:1996;1294-1302.
26. Ek J.F., Delmar M., Perzova R.et al. Role of histidine 95 on pH gating of the cardiac gapjunction protein connexin43. Circ. Res. 74:1994;1058-1064.
27. Weingart R., Maurer P. Cell-to-cell coupling studied in isolated ventricular cell pairs. Experientia. 43:1987;1091-1094.
28. De Mello W.C. Influence of the sodium pump on intercellular communication in heart fibers: effect of intracellular injection of sodium ion on electrical coupling. J. Physiol. (Lond). 263:1976;171-197.
29. Weingart R. The actions of ouabain on intercellular coupling and conduction velocity in mammalian ventricular muscle. J. Physiol. (Lond). 264:1977;341-365.
30. Burt J.M., Massey K.D., Minnich B.N. Uncoupling of cardiac cells by fatty acids: structure activity relationships. Am. J. Physiol. 260:1991;C439-C448.
31. Delmar M., Michaels D.C., Johnson T.et al. Effects of increasing intercellular resistance on transverse and longitudinal propagation in sheep epicardial muscle. Circ. Res. 60:1987;780-785.
32. Dhein S., Krüsemann K., Schaefer T. Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts. Br. J. Pharmacol. 128:1999;1375-1384.
33. Takens-Kwak B.R., Jongsma H.J., Rook M.B.et al. Mechanism of heptanol-induced uncoupling of cardiac gap junctions: a perforated patch-clamp study. Am. J. Physiol. 262:1992;C1531-C1538.
34. Hirschi K.K., Minnich B.N., Moore L.K.et al. Oleic acid differentially affects gap junction mediated communication in heart and vascular smooth muscle cells. Am. J. Physiol. 265:1993;C1517-C1526.
35. Dhein S., Hammerrath S.B. Aspects of the intercellular communication in aged hearts: effects of the gap junction uncoupler palmitoleic acid. Naunyn Schmiedebergs Arch. Pharmacol. 364:2001;397-408.
36. Schmilinsky-Fluri G., Valiunas V., Willi M.et al. Modulation of cardiac gap junctions: the mode of action of arachidonic acid. J. Mol. Cell Cardiol. 29:1997;1703-1713.
37. Burt J.M., Spray D.C. Volatile anaesthetics block intercellular communication between neonatal rat myocardial cells. Circ. Res. 65:1989;829-837.
38. He D.S., Burt J.M. Mechanism and selectivity of the effects of halothane on gap junction channel function. Circ. Res. 86:2000;E104-E109.
39. Taylor H.J., Chaytor A.T., Edwards D.H.et al. Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenon in rabbit arteries. Biochem. Biophys. Res. Comm. 283:2001;583-589.
40. Chaytor A.T., Martin P.E., Evans W.H.et al. The endothelial component of cannabinoid induced-relaxation in rabbit mesenteric artery depends on gap junctional communication. J. Physiol. (Lond). 520:1999;539-550.
41. Allen T., Iftinca M., Cole W.C.et al. Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. J. Physiol. (Lond). 545:2002;975-986.
42. Takens-Kwak B.R., Jongsma H.J. Cardiac gap junctions: three distinct channel conductances and their modulation by phosphorylating treatments. Pflügers Arch. 422:1992;198-200.
43. De Mello W.C. Atrial natriurectic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP. J. Cardiovasc. Pharmacol. 32:1998;75-79.
44. De Mello W.C. Influence of alpha-adrenergic-receptor activation on junctional conductance in heart cells: interaction with beta-adrenergicagonists. J. Cardiovasc. Pharmacol. 29:1997;273-277.
45. Kwak B.R., VanVeen T.A.B., Analbers L.J.S.et al. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp. Cell Res. 220:1995;456-463.
46. Bastide B., Hervé J.C., Délèze J. The uncoupling effect of diacylglycerol on gap junctional communication of mammalian heart cells is independent of protein kinase C. Exp. Cell Res. 214:1994;519-527.
47. Rouet-Benizeb P., Mohammadi K., Pérennec J.et al. Protein kinase C isoform expressionin normal and failing rabbit hearts. Circ. Res. 79:1996;153-161.
48. Kwak B.R., Jongsma H.J. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 157:1996;93-99.
49. Münster P.N., Weingart R. Effects of phorbol ester on gap junctions of neonatal rat heart cells. Pflügers Arch. Eur. J. Physiol. 423:1993;181-188.
50. Dhein S. Cardiac gap junctions. 1998;Karger, Basel.
51. Dhein S., Weng S., Schaefer T.et al. Role of protein kinase C in the action of antiarrhythmic peptides. FASEB J. 15:2001;465.1. [Suppl.].
52. Weng S., Lauven M., Schaefer T.et al. Pharmacological modulation of Gap Junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J. 16:2002;1114-1116.
53. Bowling N., Huang X., Sandusky G.E.et al. Protein kinase C-α and-ε modulate connexin-43 phosphorylation in human heart. J. Mol. Cell Cardiol. 33:2001;789-798.
54. Saez J.C., Nairn A.C., Czernik A.J.et al. Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocytes gap junctions. J. Mol. Cell Cardiol. 29:1997;2131-2145.
55. Duthe F., Dupont E., Verrecchia F.et al. Dephosphorylation agents depress gap junctional communication between rat cardiac cells without modifying the connxin43 phosphorylation degree. Gen. Physiol. Biophys. 19:2000;441-449.
56. Duthe F., Plaisance I., Sarrouilhe D.et al. Endogenous protein phosphatase 1 runs downgap junctional communication of rat ventricular myocytes. Am. J. Physiol. 281:2001;C1648-C1656.
57. Jeyaraman M., Tanguy S., Fandrich R.R.et al. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriencin. Mol. Cell. Biochem. 242:2003;129-134.
58. Verrecchia F., Duthe F., Duval S.et al. ATP counteracts the rundown of gap junctional channels of rat ventricular myocytes by promoting protein phosphorylation. J. Physiol. (Lond.). 516:1999;447-459.
59. De Mello W.C. The role of the renin angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II. J. Cardiovasc. Pharmacol. 20:1992;643-651.
60. De Mello W.C. Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J. Cardiovasc. Pharmacol. 23:1994;640-646.
61. Dostal D.E., Rothblum K.N., Chermin M.J.et al. Intracellular detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am. J. Physiol. 263:1992;C838-C850.
62. Cook J.L., Zhang Z., Re R.N. In vitro evidence for an intracellular site of angiotensin action. Circ. Res. 89:2001;1138-1146.
63. Suarez S., Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J. Cell Sci. 114:2001;1229-1235.
64. Popp R., Brandes R.P., Ott G.et al. Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ. Res. 90:2002;800-806.
65. Ashton A.W., Yokota R., John G.et al. Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2). J. Biol. Chem. 274:1999;35562-35570.
66. Brandes R.P., Popp R., Ott G.et al. The extracellular regulated kinases (ERK) 1/2 mediate cannabinoid-induced inhibition of gap junctional communication in endothelial cells. Br. J. Pharmacol. 136:2002;709-716.
67. Harks E.G.A., de Roos A.D.G., Peters P.H.J.et al. Fenamates: a novel class of reversible gap junction blockers. J. Pharmacol. Exp. Ther. 298:2001;1033-1041.
68. Harks E.G.A., Gamina J.P., Peters P.H.J.et al. Besides affecting intracellular calcium signaling, 2-ABP reversibly blocks gap junctional coupling in confluent monolayers, there by allowing measurement of single-cell membrane currents in undissociated cells. FASEB J. 17:2003;941-943.
69. De Mello W.C. Effect of intracellular injection of cAMP on the electrical coupling of mammalian cardiac cells. Biochem. Biophys. Res. Comm. 119:1984;1001-1007.
70. De Mello W.C. Cyclic AMP and junctional communication viewed through a multibiophysical approach. Peracchia C. Biophysics of gap junction channels. 1991;229-239 CRC Press, Boca Raton, USA.
71. Burt J.M., Spray D.C. Inotropic agents modulate gap junctional conductance between cardiac myocytes. Am. J. Physiol. 254:1988;H1206-H1210.
72. Van Rijen H.V., van Veen T.A., Hermans M.M.et al. Human connexin40 gap junction channels are modulated by cAMP. Cardiovasc. Res. 45:2000;941-951.
73. De Mello W.C. Impaired regulation of cell communication by beta-adrenergic receptor activation in the failing heart. Hypertension. 27:1996;265-268.
74. Aonuma S., Kohama Y., Akai K.et al. Studies on heart XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem. Pharm. Bull. 28:1980;3332-3339.
75. Aonuma S., Kohama Y., Makino T.et al. Studies on heart XXI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J. Pharmacobio-Dyn. 5:1982;40-48.
76. Dhein S., Tudyka T. The therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs. 49:1995;851-855.
77. Dhein S. Peptides acting at gap junctions. Peptides. 23:2002;1701-1709.
78. Kohama Y., Kawahara Y., Okabe M.et al. Determination of immunoreactive antiarrhythmic peptide (AAP) in rats. J. Pharmacobio-Dyn. 8:1985;1024-1031.
79. Kohama Y., Okimoto N., Mimura T.et al. A new antiarrhythmic peptide, N-3-(4-hydroxyphenyl)propionyl-Pro-Hyp-Gly-Ala-Gly. Chem. Pharm. Bull. 35:1987;3928-3930.
80. Aonuma S., Kohama Y., Makino T.et al. Studies on heart XXII. Yakugaku Z. Inhibitory effect of anatrial peptide on several drug induced arrhythmias in vivo. vol. 103:1983;662-666.
81. Argentieri T., Cantor E., Wiggins J.R. Antiarrhythmic peptide has no direct cardiac actions. Experientia. 45:1989;737-738.
82. Dhein S., Manicone N., Müller A.et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;174-184.
83. Müller A., Gottwald M., Tudyka T.et al. Increase in gap junction conductance by an antiarrhythmic peptide. Eur. J. Pharmacol. 327:1997;65-72.
84. Müller A., Schaefer T., Linke W.et al. Actions of the antiarrhythmic peptide AAP10 oncellular coupling. Naunyn Schmiedebergs Arch. Pharmacol. 356:1997;76-82.
85. Dhein S., Weng S., Polontchouk L.et al. Pharmacological modification of gap junctional coupling by antiarrhythmic peptides. Role of PKC. Naunyn Schmiedebergs Arch. Pharmacol. 363:2001;R99. [Suppl.].
86. Grover R., Dhein S. Spatial structure determination of antiarrhythmic peptide using nuclear magnetic resonance spectroscopy. Peptides. 19:1998;1725-1729.
87. Grover R., Dhein S. Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides. 22:2001;1011-1021.
88. Kjolbye A.L., Knudsen C.B., Jepsen T.et al. Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies. J. Pharmacol. Exp. Ther. 306:2003;1191-1199.
89. Dhein S., Larsen B.D., Petersen J.S. Effects of the new antiarrhythmic peptide ZP123 one picardial activation and repolarisation. Naunyn Schmiedebergs Arch. Pharmacol. 367:2003;R94. [Suppl.].
90. Xing D., Kjolbye A.L., Nielsen M.S.et al. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J. Cardiovasc. Electrophysiol. 14:2003;510-520.
91. De Mello W.C., Thormählen D. Effect of tedisamil on cell communication, impulse propagation, and excitability of the failing heart. Eur. J. Pharmacol. 372:1999;241-246.
92. Zhang Y.W., Morita I., Yao X.S.et al. Pretreatment with eicosapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity. Prostaglandins Leukot. Essent Fatty Acids. 61:1999;33-40.
93. Emerson G.G., Segal G.G. Endothelial pathway for conduction of hyperpolarization and vasodilatation along hamster feed artery. Circ. Res. 86:2000;94-100.
94. De Wit C., Esser N., Lehr H.-A.et al. Pentobarbital-sensitive EDHF comediates ACh induced arteriolar dilatation in the hamster microcirculation. Am. J. Physiol. 276:1999;H1527-H1534.
95. Moore L.K., Burt J.M. Gap junction function in vascular smooth muscle: influence of serotonin. Am. J. Physiol. 269:1995;H1481-H1489.
96. Fallon R.F., Goodenough D.A. Five hour half-life of mouse liver gap junction protein. J. Cell Biol. 127:1981;343-355.
97. Laird D.W. The life cycle of a connexin: gap junction formation removal and degradation. J. Bioenerg. Biomembr. 28:1996;311-317.
98. Laird D.W., Puranam K.L., Revel J.P. Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem. J. 273:1991;67-72.
99. Beardslee M.A., Laing J.G., Beyer E.C.et al. Rapid turnover of connexin43 in the adult rat heart. Circ. Res. 83:1998;629-635.
100. Darrow B.J., Laing J.G., Lampe P.D.et al. Expression of multiple connexins in cultured neonatal rat ventricular myocytes. Circ. Res. 76:1995;381-387.
101. Moore L.K., Burt J.M. Selective block of gap junction channel expression with connexin specific antisense oligonucleotides. Am.J. Physiol. 267:1994;C1371-C1380.
102. Darrow B.J., Fast V.G., Kléber A.G.et al. Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. Circ. Res. 79:1996;174-183.
103. Salameh A., Polontchouk L., Hagendorff A.et al. Protein kinase A and C regulate synthesis of the gap junction protein connexin43. FASEB J. 15:2001;711.9. [Suppl.].
104. Polontchouk L., Ebelt B., Jackels M.et al. Chronic effects of endothelin-1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J. 16:2002;87-89.
105. Dodge S.M., Beardslee M., Darrow B.J.et al. Effects of angiotensin II on expression of the gap junction channel protein connexin 43 in neonatal rat ventricular myocytes. J. Am. Coll. Cardiol. 32:1998;800-807.
106. Wang T.L., Tseng Y.Z., Chang H. Regulation of connexin43 gene expression by cyclical mechanical stretch in neonatal rat cardiomyocytes. Biochem. Biophys. Res. Commun. 267:2000;551-557.
107. Shyu K.G., Chen C.C., Wang B.W.et al. Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes. J. Mol. Cell Cardiol. 33:2001;691-698.
108. Pimentel R.C., Yamada K.A., Kleber A.G.et al. Autocrine regulation of myocyte Cx43 expression by VEGF. Res. Circ. 90:2002;671-677.
109. Doble B.W., Kardami E. Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Mol. Cell. Biochem. 143:1995;81-87.
110. Doble B.W., Ping P., Kardami E. The e subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ. Res. 86:2000;293-301.
111. Lerner D.L., Chapman Q., Green K.G.et al. Reversible down-regulation of connexin43 expression in acute cardiac allograft rejection. J. Heart Lung Transplant. 20:2001;93-97.
112. Fernandez-Cobo M., Gingalewski C., Drujan D.et al. Downregulation of connexin43 gene expression in rat heart during inflammation. The role of tumor necrosis factor. Cytokine. 11:1999;216-224.
113. Fernandez-Cobo M., Gingalewski C., Drujan D.et al. Expression of the connexin 43 gene is increased in the kidneys and lungs of rats injected with bacterial lipopolysaccharide. Shock. 10:1998;97-102.
114. Salameh A., Polontchouk L., Dhein S.et al. Chronic regulation of the expression of the gap junction protein connexin 43 in transfected HeLa cells. Naunyn Schmiedebergs Arch. Pharmacol. 368:2003;33-40.
115. Salameh A., Polonchouk L., Hagendorff A.et al. On the chronic regulation of gap junction protein connexin43 (Cx43) expression. Br. J. Pharmacol. 133:2001;215. [Suppl.].
116. Van Rijen H.V., Van Kempen M.V., Postma S.et al. Tumor necrosis factor alpha alters the expression of connexin43, connexin40 and connexin37 in human umbilical vein endothelial cells. Cytokine. 10:1998;258-264.
117. Liu M.-Y., Hattori Y., Sato A.et al. Ovariectomy attenuates hyperpolarization and relaxation mediated by endothelium-derived hyperpolarizing factor in female rat mesenteric artery: a concomitant decrease in connexin-43 expression. J. Cardiovasc. Pharmacol. 40:2002;938-948.
118. Lauf U., Giepmans B.N., Lopez P.et al. Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10446-10451.
119. Puranam K.L., Laird D.W., Revel J.P. Trapping an intermediate form of connxin43 in the Golgi. Exp. Cell Res. 206:1993;85-92.
120. Musil L.S., Goodenough D.A. Biochemical analysis of connexon assembly. Kanno Y., Kataoka K., Shiba Y., Shibata Y., Shimazu T. Intercellular communication through gap junctions. Progress in cell research. vol. 4:1995;327-330 Elesvier, Amsterdam.
121. Dahl G., Nonner W., Werner R. Attempts to define functional domains of gap junctions with synthetic peptides. Biophys. J. 67:1994;1816-1822.
122. Warner A., Clements D.K., Parikh S.et al. Specific motifs in the external loops of connexin proteins can determine gap junction formation between chick heart myocytes. J. Physiol. 488:1995;721-728.
123. Chaytor A.T., Evans W.H., Griffith T.M. Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries. J. Physiol. 503:1997;99-110.
124. Braet K., Vandamme W., Martin P.E.et al. Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap. Cell Calcium. 33:2003;37-48.
125. Kwak B.R., Jongsma H.J. Selective inhibition of gap junction channel activity by synthetic peptides. J. Physiol. (Lond.). 516:1999;679-685.
126. Beyer E.C., Berthoud V.M. Gap junction synthesis and degradation as therapeutic targets. Current Drug Targets. 3:2002;409-416.
127. Laing J.G., Tadros P.N., Green K.et al. Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes. Cardiovasc. Res. 38:1998;711-718.
128. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:1998;397-403.
129. Garcia-Dorado D., Inserte J., Ruiz-Meana M.et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation. 96:1997;3579-3586.